中文名 | PF-3845 |
英文名 | PF-3845 |
别名 | 化合物PF-3845 N-3-吡啶-4-[[3-[[5-(三氟甲基)-2-吡啶]氧基]苯基]甲基]-1-哌啶羧酰胺 N-(吡啶-3-基)-4-(3-((5-(三氟甲基)吡啶-2-基)氧基)苄基)哌啶-1-酰胺 N-3-吡啶基-4-[[3-[[5-(三氟甲基)-2-吡啶基]氧基]苯基]甲基]-1-哌啶甲酰胺 PF-3845 N-3-吡啶-4-[[3-[[5-(三氟甲基)-2-吡啶]氧基]苯基]甲基]-1-哌啶羧酰胺 |
英文别名 | PF 3845 PF-3845 PF 3845 hydrate 4-(3-(5-(trifluoromethyl)pyridin-2-yloxy)benzyl)-N-(pyridin-3-yl)piperidine-1-carboxamide N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxami N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide hydrate N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide PF 3845 |
CAS | 1196109-52-0 |
化学式 | C24H23F3N4O2 |
分子量 | 456.46 |
密度 | 1.323±0.06 g/cm3(Predicted) |
沸点 | 623.6±55.0 °C(Predicted) |
溶解度 | DMSO: ≥ 45 mg/mL |
酸度系数 | 14.14±0.40(Predicted) |
存储条件 | 2-8°C |
外观 | 粉末 |
颜色 | white to tan |
MDL号 | MFCD21365072 |
体外研究 | PF-3845 (0.5 nM-10 μM; 40 min) inhibits human FAAH-1 (IC 50 =18 nM) in a concentration-dependent manner, and shows negligible activity against FAAH-2 (IC 50 >10 μM) in COS-7 cells. PF-3845 (0.1-1000 μM; 48 h) significantly decreases the Colo-205 cell viability. |
体内研究 | PF-3845 (1-30 mg/kg; p.o.) produces cannabinoid receptor-dependent reductions in inflammatory pain in rat. PF-3845 (10 mg/kg; a single i.p.) selectively inhibits FAAH in mice for up to 24 hours. PF-3845 (10 mg/kg; a single i.p.) causes a dramatic and sustained elevation in Anandamide (AEA) in mice. Animal Model: Male Sprague-Dawley rats (200g- 250g) are injected CFA Dosage: 1, 3, 10, 30 mg/kg Administration: Oral administration Result: Caused a dose-dependent inhibition of mechanical allodynia with a minimum effective dose (MED) of 3 mg/kg. |
危险品标志 | T - 有毒物品 |
风险术语 | 25 - 吞食有毒。 |
安全术语 | 45 - 若发生事故或感不适,立即就医(可能的话,出示其标签)。 |
危险品运输编号 | UN 2811 6.1 / PGIII |
WGK Germany | 3 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!